| Kaitlyn Cornella-carlson, OTR | |
|
17280 W North Ave, Brookfield, WI 53045-4366 | |
| (262) 928-8830 | |
| Not Available |
| Full Name | Kaitlyn Cornella-carlson |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 17280 W North Ave, Brookfield, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831821891 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 7202-26 (Wisconsin) | Primary |
| Provider Name | Prohealth Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356322440 PECOS PAC ID: 3476465188 Enrollment ID: O20031103000066 |
News Archive
Two young researchers working at the MIPT Laboratory of Nanooptics and Plasmonics, Dmitry Fedyanin and Yury Stebunov, have developed an ultracompact highly sensitive nanomechanical sensor for analyzing the chemical composition of substances and detecting biological objects, such as viral disease markers, which appear when the immune system responds to incurable or hard-to-cure diseases, including HIV, hepatitis, herpes, and many others.
VitalWear, Inc. (www.vitalwear.com), a leader in thermal therapy medical devices announced that the San Francisco Business Times honored the company as one of the fastest-growing private companies in the Bay Area for 2009. VitalWear was ranked #17 out of 100 companies.
Researchers at the Board of Governors Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have shown for the first time that it is possible to sustain therapeutic gene expression in the central nervous system for up to a year, even in the presence of an anti-viral immune response mechanism that is normally present in humans.
Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration's Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.
The older the woman, the more likely it is that consistent use of calcium and vitamin-D supplements will play a role in reducing her risk for osteoporosis, according to the results of a large national clinical trial conducted as part of the Women's Health Initiative (WHI).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaitlyn Cornella-carlson, OTR 1012 N Bluespruce Cir, Hartland, WI 53029-8681 Ph: (262) 347-8002 | Kaitlyn Cornella-carlson, OTR 17280 W North Ave, Brookfield, WI 53045-4366 Ph: (262) 928-8830 |
News Archive
Two young researchers working at the MIPT Laboratory of Nanooptics and Plasmonics, Dmitry Fedyanin and Yury Stebunov, have developed an ultracompact highly sensitive nanomechanical sensor for analyzing the chemical composition of substances and detecting biological objects, such as viral disease markers, which appear when the immune system responds to incurable or hard-to-cure diseases, including HIV, hepatitis, herpes, and many others.
VitalWear, Inc. (www.vitalwear.com), a leader in thermal therapy medical devices announced that the San Francisco Business Times honored the company as one of the fastest-growing private companies in the Bay Area for 2009. VitalWear was ranked #17 out of 100 companies.
Researchers at the Board of Governors Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have shown for the first time that it is possible to sustain therapeutic gene expression in the central nervous system for up to a year, even in the presence of an anti-viral immune response mechanism that is normally present in humans.
Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration's Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.
The older the woman, the more likely it is that consistent use of calcium and vitamin-D supplements will play a role in reducing her risk for osteoporosis, according to the results of a large national clinical trial conducted as part of the Women's Health Initiative (WHI).
› Verified 5 days ago
Mrs. Kay Lynne Luck, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17280 W North Ave, #104, Brookfield, WI 53045 Phone: 262-780-0707 Fax: 262-780-0717 | |
Mary Teresa Ortell, OCCUPATIONAL THERAPI Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 18740 W Bluemound Rd, Brookfield, WI 53045 Phone: 262-641-8728 Fax: 262-797-8306 | |
Paige Nicole Splittgerber, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3360 Gateway Rd, Brookfield, WI 53045 Phone: 262-923-7101 | |
Mrs. Kimberly Ann Beckmann, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17280 W North Ave, # 104, Brookfield, WI 53045 Phone: 262-780-0707 Fax: 262-780-0717 | |
Cindy Van Valin, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17280 W North Ave, #104, Brookfield, WI 53045 Phone: 262-780-0707 | |
Kenneth Siebels, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19395 W Capitol Dr Ste 200, Brookfield, WI 53045 Phone: 262-923-7101 | |
Carol Marie Wingenter, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3285 Sunnyview Ln, Brookfield, WI 53005 Phone: 262-783-9863 |